arginyl-glycyl-aspartic acid and arginyl-glycyl-aspartyl-phenylalanine

arginyl-glycyl-aspartic acid has been researched along with arginyl-glycyl-aspartyl-phenylalanine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Simone, M; Di Leva, FS; Hegemann, JD; Kessler, H; Knappe, TA; Marahiel, MA; Marinelli, L; Novellino, E; Xie, X; Zahler, S; Zimmermann, M	1
Bovy, PR; Dayringer, H; Garland, RB; Lindmark, RJ; McMackins, DE; Rico, JG; Rogers, TE; Tjoeng, FS; Tóth, MV; Zablocki, JA	1

Other Studies

2 other study(ies) available for arginyl-glycyl-aspartic acid and arginyl-glycyl-aspartyl-phenylalanine

Article	Year
Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides. Journal of medicinal chemistry, 2014, Jul-10, Volume: 57, Issue:13 Topics: Bacteriocins; Cell Adhesion; Human Umbilical Vein Endothelial Cells; Humans; Integrin alphaVbeta3; Models, Molecular; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Peptides; Protein Conformation; Snake Venoms	2014
Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents. Bioorganic & medicinal chemistry, 1994, Volume: 2, Issue:9 Topics: Administration, Oral; Amino Acid Sequence; Animals; Benzamidines; Dogs; Female; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Structure-Activity Relationship	1994

Article

Year

Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides.

Journal of medicinal chemistry, 2014, Jul-10, Volume: 57, Issue:13

Topics: Bacteriocins; Cell Adhesion; Human Umbilical Vein Endothelial Cells; Humans; Integrin alphaVbeta3; Models, Molecular; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Peptides; Protein Conformation; Snake Venoms

2014

Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents.

Bioorganic & medicinal chemistry, 1994, Volume: 2, Issue:9

Topics: Administration, Oral; Amino Acid Sequence; Animals; Benzamidines; Dogs; Female; Male; Molecular Sequence Data; Oligopeptides; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Structure-Activity Relationship

1994